“…The risk of bias from patient selection was judged to be high or unclear in 13 of the included studies: 4 studies limited the nodule size within a certain scope [16,17,21,25]; 5 studies excluded difficult-to-diagnose nodules [15,[25][26][27]31]; and 4 studies were unclear about whether there were selected co-horts and inappropriate exclusions [14,19,23,29]. The risk of bias from the reference standard was considered to be unclear in 2 of the included studies [14,23]. The risk of bias from flow and timing was considered to be high or unclear in 7 of the included studies, and these studies adopted pathological examination, fine needle aspiration, and ultrasound as reference standards for diagnosing benign nodules [19,22,25,27,28,30,31].…”